At GCEngine platform, tRNA molecules serve as precision tools that bridge aminoacyl-tRNA synthetase (aaRS) activation and ncAA incorporation during orthogonal translation. To achieve consistent performance, these engineered tRNAs must be purified with both molecular specificity and functional preservation.
Our affinity-based tRNA isolation service utilizes tag-assisted capture strategies to selectively recover target tRNA species from complex RNA mixtures. Depending on the project, we can use biotinylated antisense oligonucleotides, LNA/DNA mixmers, EF-Tu–based affinity, or direct 3'-end biotinylation of synthetic tRNAs to enrich defined tRNA pools with high purity and functional integrity.
Traditional size-based purification methods can separate RNA species by length, but they lack specificity for individual tRNA variants or engineered constructs. Affinity-tag strategies overcome this limitation by exploiting selective biochemical interactions between a tag (sequence or chemical moiety) on a capture oligonucleotide or on the tRNA itself and a complementary ligand immobilized on a resin or matrix.
Fig.1 Purification of specific tsRNAs. (Drino, A., et al., 2020)
To meet the diverse requirements of engineered and orthogonal tRNA purification, the GCEngine platform offers a suite of affinity-tag isolation strategies. Each method is designed to maximize recovery, selectivity, and structural preservation while adapting to different tRNA chemistries and research goals.
Sequence-Directed Capture with Biotinylated Antisense DNA
We design a short, highly specific DNA oligo complementary to the target tRNA region; the oligo is biotinylated and immobilized on streptavidin beads/columns. Hybridization pulls down the target tRNA; gentle, low-salt elution releases it for immediate use. This approach is widely used for tRNA/tsRNA purification and scales well.
LNA/DNA Mixmer
Antisense Capture
Locked-nucleic-acid (LNA) mixmers provide higher Tm and specificity with shorter probes—useful when target regions are structured or GC-rich. We immobilize 3'-biotinylated LNA/DNA mixmers on streptavidin beads for rapid capture and clean release. This method is established for selective RNA isolation from complex samples.
Oligonucleotide Affinity
Chromatography
For high-capacity or prep-scale runs, we use columns bearing immobilized complementary DNA that can be used to purify a single tRNA isoacceptor in one step under suitable conditions. This classical, sequence-specific chromatography has been described for tRNAs and remains reliable for preparative isolation with excellent selectivity.
Functional-State Enrichment via EF-Tu Affinity
When you need the aminoacylated fraction specifically, we can capture aa-tRNA using immobilized elongation factor Tu (EF-Tu) or EF-Tu–based columns, then elute under conditions that can help preserve charging where required. This is a powerful option to enrich translationally ready tRNA pools.
Direct 3'-End Biotin Tag on tRNA
For engineered or IVT products, a 3' biotin handle enables straightforward purification using streptavidin media. The tag can be kept or removed after elution, simplifying downstream steps.
For tRNAs used in aminoacylation and translation, we design 3' biotin tags to be removable, or position them beyond the native CCA sequence. This preserves the canonical structure for proper recognition by aaRS and EF-Tu.
Tell us your target tRNA, expected yield/scale, and whether you need the aa-tRNA fraction. We'll match the best affinity strategy (e.g., LNA capture for structured targets; EF-Tu for aminoacylated pools; column-format oligo affinity for scale-up). Contact us today to design a custom affinity-based tRNA isolation strategy and accelerate your genetic code expansion projects.
All our services are exclusively intended for preclinical research purposes. They are not intended for diagnostic, therapeutic, or patient management applications.
A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.